Robots & Robotics

MegaRobo Raises Nearly $200M for AI-Powered Robotic Laboratories

MegaRobo has raised nearly $200 million with Oman Investment Authority and CMB International participating, backing robotic labs that connect AI-designed experiments with physical results.

By Kseniia Klichova | Edited by Daniel Krauss Published:
MegaRobo Raises Nearly $200M for AI-Powered Robotic Laboratories
MegaRobo is expanding the robotic laboratory infrastructure that connects AI-designed experiments with physical testing after raising nearly $200 million. Image: MegaRobo

Key Notes

  • MegaRobo has raised nearly $200 million in new financing with participation from Oman Investment Authority, CMB International and existing investors.
  • Its infrastructure connects AI models and agents with robotic laboratories, scientific instruments and structured experimental feedback.
  • The company plans to expand its AI for Science business internationally and reports approximately $600 million raised across multiple rounds, without disclosing a new valuation.

MegaRobo Technologies has raised nearly $200 million to expand the infrastructure connecting AI with robotic laboratories and physical experiments. Oman Investment Authority, the sovereign wealth fund of Oman, joined the financing alongside new investor CMB International and existing backers Asia Investment Capital, Granite Asia and Sinovation Ventures.

The company’s November 19 announcement directs the capital toward core technology and international expansion of its AI for Science business. The proposition is practical: a model can propose an experiment, but instruments and robots still have to carry it out and return usable observations.

AI Plans Meet a Physical Experiment

MegaRobo calls its underlying architecture One Intelligence Stack. It brings models and agents together with workflows, software, scientific instruments, robotics and experimental feedback. The company presents that combination as a reusable foundation for connecting digital reasoning with controlled physical work.

Through Megalaxy Lab, researchers can configure experiments, track execution and receive structured results. Its published workflow starts with a research objective and sequence designs, then moves through automated testing and data delivery. Services include screening, binding characterization and thermostability analysis.

For robotics, the important connection is between the instruction and the record of what happened. A laboratory system must preserve sample identity, instrument settings and the relationship between each procedure and its measurements. Those details let a scientist or model interpret a result rather than merely receive a number.

Experimental Results Feed the Next Design Cycle

Megalaxy Lab describes an interface through which AI agents can place experiment orders, track progress and retrieve data. That creates a route from computational design to physical validation and back into the next iteration. It also makes integration with instruments and sample-handling equipment part of the AI system’s practical usefulness.

The existing Poreva Open protein-design competition offers a specific example. It plans wet-lab validation of more than 10,000 designs across five challenges, with experimental validation scheduled from December 2026 into April 2027. The program is intended to compare designs against measured results, rather than predictions alone.

Such testing can identify which candidates deserve further work, including unsuccessful designs that help define a model’s limits. It is one stage of scientific evaluation; a successful laboratory assay does not establish a medicine’s safety or effectiveness in people.

Funding Expands the Robotics Layer Behind Research

MegaRobo says it has raised approximately $600 million across multiple rounds and plans continued expansion across North America, Europe, the Middle East and Asia. The latest release does not disclose a valuation or identify a lead investor for the new financing.

Our Opentrons funding report examined another effort to connect AI-directed research with laboratory execution. The Multiply Labs story covers robots coordinating instruments in pharmaceutical manufacturing, a different stage of the life-sciences workflow. MegaRobo’s new capital supports the experimental layer: making physical testing accessible to researchers and software while retaining the traceability needed to understand its results.

Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.

Artificial Intelligence (AI), Business & Markets, News, Robots & Robotics, Startups & Venture